Tag: Novo Nordisk

• Investments Stock Market

  Down 70%? Don’t Let it Happen to You

  Concentrated stock holdings can be risky. Novo Nordisk is just the latest poster child for this fact that everyone knows, but not everyone wants to do something about. Novo Nordisk has fallen from a high of about $142 per share in June 2024 to about $51 per share in August…

  August 12, 2025
• Health & Wellness Risk Stock Market

  

  Novo Nordisk: Time to Sell?

  Novo Nordisk shareholders have grown fat even as the obesity drug company’s customers have been losing weight. From relative obscurity just five years ago, Novo Nordisk has become the most valuable company in Europe. The promise of future returns is built into the stock price. In this post, we look…

  January 9, 2024